Anthem Biosciences Ltd, a CRDMO founded in 2006, offers end-to-end drug discovery-to-manufacturing services and specialises ...

Indian equity benchmarks edged lower on Wednesday, mirroring weakness in Asian markets following a rise in US inflation.

The Committee on Economic Development and Agriculture, chaired by Senator Hubert L. Frederick, convened at the Frits E. Lawaetz Legislative Conference Room to receive updates from both the University ...

Anthem Biosciences’ IPO puts the spotlight on India’s contract drug manufacturing sector, as investor appetite swells and global firms diversify away from China.

Divi Resorts is bringing back its popular Kids Stay & Eat Free program for a limited time! On all-inclusive stays, kids 12 ...

Anthem ticks all the boxes. But with lofty valuations and limited margin headroom, analysts warn the IPO may not deliver ...

Anthem Biosciences' IPO witnessed strong investor interest, being oversubscribed 2.08 times on Day 2, driven by NIIs.

Anthem Biosciences is a leading player in the fast growing CRDMO (Contract Research, Development and Manufacturing ...

Anthem Biosciences IPO on Day 2 with moderate success, price band ₹540-570, 35% reserved for retail investors.

According to market observers, unlisted shares of Anthem Biosciences Ltd are currently trading at Rs 670 against its upper ...

Manufacturing Sector Stocks - Check here complete list of Manufacturing Stocks in India, their live stock price, top gainers and top losers for the day at financialexpress.com.

Despite a generally weak market, the Nifty Pharma index advanced by 0.35% on Monday, with Laurus Labs Ltd. and Mankind Pharma Ltd. leading the gains.